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ABSTRACT
Background. Doppler ultrasound (DU) monitoring early after arteriovenous fistula (AVF) creation allows the identification of
low blood flow (Qa) requiring prompt revision, but it is costly (needs skilled operators and technical instruments) and is not
available in all dialysis units. Therefore alternative first-line methods to measure Qa would be welcomed. We reasoned that
once an AVF is created, an increment in central venous oxygen saturation (ScvO2) is predictable and proportional to Qa.
Methods. Accordingly, in patients receiving dialysis through a central venous catheter (CVC) in whom an AVF was created,
we measured, by means of blood gas analysis, the ScvO2 increment before and after manual compression of the
arteriovenous shunt and verified its correlation with DU-measured Qa.
Results. We sampled blood gas in 18 patients with CVC and AVF before and after 30 s manual compression of the AVF.
ScvO2 averaged 70.56 3% before and 65.26 3% after AVF closure, with an average drop of 5.163% (range 1–12). AVF Qa,
which was measured within 24 h by means of DU, averaged 6356349 mL/min (range 50–1300) and was strictly and
positively correlated with DScvO2 (r ¼ 0.954, P<0.0001).
Conclusions. Therefore we suggest that in patients with CVC and a newly created AVF, it is possible to monitor AVF Qa
without DU by simply measuring blood gas and DScvO2. This technique is simple, cheap, repeatable, non-invasive and
operator independent and represents a new useful screening test to detect delayed AVF access maturation deserving
prompt DU measurement and surgical revision. It helps to quickly identify patients in urgent need of DU verification and
possible surgical revision. Regrettably, it is applicable only in patients with CVC.
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INTRODUCTION
Primary arteriovenous fistula (AVF) is the best vascular access
for haemodialysis (HD) patients. Despite technical progress, the
early failure rate of AVFs (within 3 months of creation) still aver-
ages 20–30% [1], with higher percentages (50–60%) in fragile
patients [2]. Currently there are no unique parameters that can
predict AVF failure risk, but recent papers highlight AVF blood
flow (Qa) as a key parameter to identify a high risk for new AVFs
deserving urgent revision to avoid thrombosis [3–5]. Since early
detection and pre-emptive repair improve long-term AVF out-
come, close monitoring of Qa is mandatory, in particular, in
patients with predictably slow and difficult AVF maturation
(e.g. late referrals, elderly or diabetics) [6, 7]. However, Doppler
ultrasound (DU), the gold standard technique to monitor AVF
Qa, although non-invasive, reliable and applicable in any pa-
tient at any stage of maturation, is costly, requires a skilled op-
erator with adequate equipment and is not commonly available
in all dialysis units. Therefore, alternative first-line methods to
measure Qa would be welcomed.
We describe here a new method to estimate Qa that relies on
the evaluation of blood oxygen saturation and thus requires
only a blood gas analyser, a device much more commonly avail-
able in nephrology and dialysis units. This low-cost, non-
invasive technique could benefit patients dialysed through a
central venous catheter (CVC) before AVF creation and during
its maturation.
MATERIALS ANDMETHODS
Rationale
We reasoned that once an AVF is created, some increase in cen-
tral venous oxygen saturation (ScvO2) would be observed, likely
proportional to the Qa (Figure 1). We thus believed that in
patients receiving dialysis through a CVC, we could detect
changes in ScvO2. Moreover, manual compression of the AV
shunt is expected to produce quick changes in blood oxygena-
tion such that the differences in ScvO2 could be used to infer Qa.
Patient selection
Eligibility criteria for this study were age 18 years, chronic HD
treatment by means of a permanent jugular CVC, the presence
of an AVF and no evidence of acute underlying illness.
Exclusion criteria were evidence of a displaced or malfunction-
ing CVC, chronic obstructive pulmonary disease or arterial oxy-
gen saturation (SaO2)< 90% in resting condition and severe
refractory anaemia (haemoglobin <9 g/dL despite adequate
erythropoietin and iron supplement therapy).
From January to December 2017 we enrolled all patients in
our unit who had both a CVC and AVF that fulfilled the eligibil-
ity criteria and, in particular, who had capillary SaO2>90% as
measured from any finger of the non-AVF arm [peripheral pulse
oximeter (Max Puls Two; EuroSanitas, Montecatini-Terme
Pistoia, Italy); accuracy 2%].
In all patients before each of the weekly dialysis sessions,
we measured blood oxygen (GEM 4000 Premier; Instrumentation
Laboratory, Milan, Italy; SO2 accuracy 2%) from the CVC ‘arterial’
branch both before and after 30 s of AVF closure. AVF flow inter-
ruption was obtained soon after heparin administration by
manually compressing the AVF 1 cm distal to the anastomosis.
Effective flow interruption was confirmed by verifying the dis-
appearance of the bruit with a phonendoscope.
The change in ScvO2 (DScvO2) was the difference between
ScvO2 with the AVF open and ScvO2 with the AVF closed. In
each patient the Qa was then measured by DU within a maxi-
mum of 24 h, with the DU operator blinded to the ScvO2 results.
In three patients the same measurements were repeated in five
consecutive dialysis sessions, by different nurses, to verify the
repeatability of the method. In one patient, measurements were
repeated after 1 week and after 1, 2 and 3 months of AVF crea-
tion to verify Qa changes along with AVF maturation.
The present study is a subanalysis of the ‘Studio No. 107055/
2017’ approved by the Ethics Committee of the ASL Rm2 and
was performed in accordance with the Declaration of Helsinki.
Written informed consent was obtained from all participants.
RESULTS
We included 18 CVC–AVF patients (10 male and 8 female, age
63.2615 years, HD vintage 19.8615 months, SaO2 range 93–
99%; Table 1). ScvO2 before AVF closure averaged 70.563% and
ScvO2 after AVF closure averaged 65.263%. This last value is in-
deed lower than normal (ScvO2 normal value 70%), but is in
agreement with those observed in HD patients [8]. As a result,
DScvO2 averaged 5.16 3% (range 1–12). AVF Qa measured with
DU averaged 6356 349 mL/min (range 50–1300) and was strictly
and positively correlated with DScvO2 (r¼ 0.954, P < 0.0001). We
FIGURE 1: (A) With jugular CVC, we have an easy access to ScvO2. (B) When AVF is created, we have a change of ScvO2 proportional to AVF shunt.
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thus considered that we could estimate AVF flow (eQa) as a
function of DScvO2 with the following linear regression model
equation (Figure 2):
eQa ¼ 45.82þ 111.54DScvO2
No side effect was recorded secondary to the procedure. In
the three patients who had DScvO2 measured five consecutive
times, the maximum calculated difference was <6.6%, pointing
to substantial stability and repeatability of the parameter. In the
patient who was sampled after 1 week and 1, 2 and 3 months
from AVF creation, DScvO2 values were 1.6% (eQa 224 mL/min),
2.7% (eQa 346 mL/min), 3.6% (eQa 440 mL/min) and 3.5% (eQa
430 mL/min), respectively, consistent with the corresponding DU
Qa values of 220, 330, 390 and 380 mL/min, respectively (Figure 3).
DISCUSSION
Our study shows that in patients with a CVC and AVF, it is pos-
sible to estimate AVF Qa by means of DScvO2 measurement,
which could thus represent a new tool in monitoring vascular
access maturation. Since AVF Qa assessment is required to
identify an AVF at risk of failure, having a first-line screening
method to identify an AVF with a reduced Qa deserving urgent
DU seems useful. Indeed, as shown in Figure 2, DScvO2 values of
3% indicate flows of 300 mL/min, which is the threshold
value for an AVF at increased risk of thrombosis. Furthermore,
unlike other methods for measuring Qa during an HD session,
this method can be used during AVF maturation without posi-
tioning fistula needles, before the AVF is ready for venipunc-
ture. For this reason, our simple, cheap, repeatable, non-
invasive and operator-independent approach seems to be a use-
ful screening tool to monitor AVF flow and maturation without
dedicated instruments and expert operators. It helps to quickly
identify patients in urgent need of DU verification and possible
surgical revision. Regrettably, and as a limitation, it is applicable
only in patients with a CVC.
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FIGURE 2: Correlation test of DScvO2 and Qa evaluated with DU.
Table 1. Clinical and biochemical characteristics of the population
Patients n¼ 18
Male/female, n 10/8
Age (years) 63.2615
HD vintage (months) 19.8615
AVF vintage (months) 2.56 2.2
BMI (kg/m2) 25.16 1.2
ABI 0.76 0.1
Haemoglobin (g/dL) 10.16 1.1
Kt/V 1.486 0.0
nPCR (g/kg/day) 1.036 0.0
SaO2 (%), mean6SD (range) 96.8 6 0.1 (99–93)
ScvO2 AVF closed (%) 65.26 3.2
ScvO2 AVF opened (%) 70.56 3.3
DScvO2 (%), mean6SD (range) 5.16 3.1 (1–12)
Qa (mL/min via DU), mean6SD (range) 6356 349 (50–1300)
Values are presented as mean6SD unless stated otherwise.
BMI, body mass index; ABI, ankle brachial index; Kt/V, urea clearance (K)
multiplied by dialysis time (t) divided by the volume of water in the body; nPCR,
normalized protein catabolic rate; Qa, vascular access flow.
FIGURE 3: AVF maturation over time for one patient. DU Qa, eQa and DScvO2
were evaluated at 7, 30, 60 and 90 days after AVF creation with a strictly concor-
dant trend.
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